Patients at core
Patients remain the backbone of every Novartis Alcon project, Dr. Liew continued. A formal Patient Declaration explicitly lays out the company’s commitment to patients–from improving access to taking the patient perspective in the planning and execution of research and development.
“The patient perspective guides everything we do, from the types of drugs we develop to taking patient needs and preferences into consideration in designing clinical trials and in designing more effective ways of informing them of trial results,” Dr. Liew pointed out. “Novartis has collaborated with more than 800 patient organizations and we are looking forward to listening to your ideas in the area of glaucoma.”